Where does Mike Carusi work?

Mike Carusi is General Partner at Lightstone Ventures and Board director at Allay Therapeutics and Board director at Shoulder Innovations and Board director at Nuvaira.

What does Mike Carusi invest in?

Mike Carusi invests in Biotech, Healthtech, Medical Devices.

What check size does Mike Carusi write?

Mike Carusi typically writes checks of $100K – $5M.

What boards does Mike Carusi sit on?

Mike Carusi holds tracked board seats at Gynesonics, Nuvaira, Shoulder Innovations.

Where did Mike Carusi go to school?

Mike Carusi studied at UCL (Bachelor of Science (BSc) (Hons), Molecular Biology); University of Oslo (Doctor of Philosophy - PhD, Molecular Biology); University of Oslo (Master’s Degree, Molecular Biology).

Mike Carusi

Investor

General Partner at Lightstone Ventures · Board director at Allay Therapeutics · Board director at Shoulder Innovations · Board director at Nuvaira

Menlo Park, California

Writes $100K – $5M checks · typically $1.5M

About

Mike Carusi is a former medtech CEO who led Adiana to Hologic and now a VC insists on early reimbursement strategies, spending significant time on coverage pathways and value demonstration.

Contact· published on Mike's own website

m•••@lightstonevc.comreveal

Invests in

BiotechHealthtechMedical Devices

Board director at Allay Therapeutics

Intro paths

→

In turn, Mike can intro founders to Allay Therapeutics's investors below.

Allay Therapeutics's investors · 5

Arboretum VenturesAnn Arbor · $5M – $15M checks · since 2025 ClavystBioSingapore · since 2025 Lightstone VenturesPortola Valley · since 2019 New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks SGInnovateSingapore · $652K – $18M checks

Board director at Shoulder Innovations

Intro paths

→

In turn, Mike can intro founders to Shoulder Innovations's investors below.

Shoulder Innovations's investors · 9

APERTURE Venture PartnersBoston · $1M – $5M checks Arboretum VenturesAnn Arbor · $5M – $15M checks Genesis Innovation GroupGrand Rapids Global BrainTokyo · $100K – $184M checks Invest MichiganNorthville · $100K – $250K checks Lightstone VenturesPortola Valley · since 2025 US Venture PartnersMenlo Park · $500K – $10M checks · since 2025 Wakestream VenturesGrand Rapids · $150K – $500K checks WMU Biosciences Research & Commercialization CenterKalamazoo · $100K – $250K checks

Board director at Nuvaira

Intro paths

→

In turn, Mike can intro founders to Nuvaira's investors below.

Nuvaira's investors · 3

Lightstone VenturesPortola Valley · since 2018 Qiming Venture PartnersBeijing · $5M – $134M checks · since 2022 Windham Capital PartnersNew York · $1M – $5M checks

Co-founders at Nuvaira

Martin MayseCo-founder

Steve DimmerCo-founder

Experience

Hadean VenturesPrincipalcurrent2024 — present
Hadean VenturesSenior Associate2023 — 2024Oslo, Norway
Hadean VenturesInvestment Associate2021 — 2023Oslo, Norway
Hadean VenturesInvestment Analyst2020 — 2021
The Life Science ClusterBoard Membercurrent2025 — present
TargED BiopharmaceuticalsBoard Observercurrent2022 — present
Gesynta Pharma ABBoard Observercurrent2020 — present
SciRhomBoard Member2024 — 2026
SAGA DiagnosticsBoard Observer2021 — 2026
Norges forskningsrådSubject Matter Expert / Referee2020 — 2023
Innovayt A/SInnovation Consultant / Project Developer2018 — 2020Oslo Area, Norway
Oslo University HospitalPostgraduate Researcher (PhD Candidate)2015 — 2018Oslo Area, Norway
InformaAssistant Commissioning Editor2012 — 2013Fleet Street, London
Medical Research CouncilFreelance Science Writer at Biomedical Picture of the Day2012 — 2013London, United Kingdom
REGISTRAT MAPIMarket Research Intern2012London Area, United Kingdom

Skills & more

Languages English · Norwegian

From Mike's professional profile.

Deals · 3

Shoulder InnovationsBoard seat

via Lightstone Ventures · filed Mar 2025 · $40.1M raise

GynesonicsBoard seat

via Lightstone Ventures · filed Jan 2019 · $77M raise

NuvairaBoard seat

via Lightstone Ventures · filed May 2018 · $8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Lightstone Ventures

Caroline Gaynor

Partner at Lightstone Ventures

Christina Isacson

Partner at Lightstone Ventures

Christina Isacson, Ph.D.

Partner at Lightstone Ventures

Doug Treco

Advisor at Lightstone Ventures

Doug Treco, Ph.D.

Advisor at Lightstone Ventures

Frank D. Lee

Advisor at Lightstone Ventures

H. Martin Seidel

Advisor at Lightstone Ventures

H. Martin Seidel, Ph.D.

Advisor at Lightstone Ventures

Network2

Caroline Gaynor

Partner at Lightstone Ventures

Christina Isacson

Partner at Lightstone Ventures

Investors connected to Mike in public investor directories — a warm-intro map.

Frequently asked questions

Who is Mike Carusi?: Mike Carusi is a former medtech CEO who led Adiana to Hologic and now a VC insists on early reimbursement strategies, spending significant time on coverage pathways and value demonstration.
Where does Mike Carusi work?: Mike Carusi is General Partner at Lightstone Ventures and Board director at Allay Therapeutics and Board director at Shoulder Innovations and Board director at Nuvaira.
What does Mike Carusi invest in?: Mike Carusi invests in Biotech, Healthtech, Medical Devices.
What check size does Mike Carusi write?: Mike Carusi typically writes checks of $100K – $5M.
What boards does Mike Carusi sit on?: Mike Carusi holds tracked board seats at Gynesonics, Nuvaira, Shoulder Innovations.
Where did Mike Carusi go to school?: Mike Carusi studied at UCL (Bachelor of Science (BSc) (Hons), Molecular Biology); University of Oslo (Doctor of Philosophy - PhD, Molecular Biology); University of Oslo (Master’s Degree, Molecular Biology).

Same school

Also attended UCL523

Demis HassabisCo-founder & CEO of Google DeepMind André DuboisInvestor at Index Ventures Frédérique DameInvestor at GV (Google Ventures)Jonas VetterleInvestor at Moonfire Ventures Marie FerriInvestor at Daphni Elena PantaziPartner & Head of Platform at Northzone

+ 517 more

Also attended University of Oslo55

Line Svinndal LorentsenInvestor at Investinor PatrickInvestor at Investinor Nina MahmoudpourGeneral Counsel & Chief of Staff at Type One Ventures Ole RuchManaging Partner at Nordstar Marianne UtengManaging Director at Novartis Venture Fund Andreas SlettvollVenture Partner at World Fund

+ 49 more

Also attended Quantic School of Business and Technology78

Victoria BondarchukDirector at Marlin Equity Partners Hillary LehrManaging Director, Fund V at Higher Ground Labs Arun IyerInvestor at Green Flag Alex RendónInvestment Associate at BuenTrip Ventures Oluwatofunmi IdowuVenture Analyst at LoftyInc Capital Claire CrowtherVice President, Strategy & Operations at Underscore VC

+ 72 more

Shared employers

Also worked at The Life Science Cluster1

Øivind EngerPartner, Life Sciences at Sarsia Management AS

Also worked at TargED Biopharmaceuticals12

Claus AnderssonGeneral Partner at Sunstone Capital Thijs Cohen TervaertPartner at Inkef Cher Shen KiarAssociate at Inkef Caroline GoddeerisPartner at Fund+Halina NovakPrincipal at Fund+Mariette van der VeldenPartner at Curie Capital

+ 6 more

Also worked at Gesynta Pharma AB7

Jonas JendiInvestor at Industrifonden Jonathan IlickiInvestor at Industrifonden Pekka SimulaPartner, Innovestor Life Science at Innovestor Ventures Markus DietrichSenior Investment Associate at Hadean Ventures Camilla OlsenImpact & ESG Manager at Hadean Ventures Daniele ScarinciFounder and Managing Partner at XGEN Venture

+ 1 more

Also worked at Norges forskningsråd7

Siri KalvigCEO at Nysnø Climate Investments Stian NygaardInvestment Director at Yara Growth Ventures Karianne MellebyInvestment Director at Kistefos Venture Capital Abby BeersFP&A Manager at Avalon BioVentures Farzad Abdi-DezfuliPartner Life Sciences at Sarsia Management AS Tanja HoelManaging Director at Blue Revolution Investments G.P.

+ 1 more